Alpha Financial Statements From 2010 to 2025
| ACOGF Stock | USD 6.41 0.06 0.94% |
Check Alpha Cognition financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alpha Cognition's main balance sheet or income statement drivers, such as , as well as many indicators such as . Alpha financial statements analysis is a perfect complement when working with Alpha Cognition Valuation or Volatility modules.
Alpha |
Alpha Cognition OTC Stock Shares Owned By Insiders Analysis
Alpha Cognition's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Alpha Cognition Shares Owned By Insiders | 29.84 % |
Most of Alpha Cognition's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alpha Cognition is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 29.84% of Alpha Cognition are shares owned by insiders. This is 96.57% higher than that of the Healthcare sector and 110.44% higher than that of the Biotechnology industry. The shares owned by insiders for all United States stocks is 195.74% lower than that of the firm.
Alpha Cognition Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Alpha Cognition's current stock value. Our valuation model uses many indicators to compare Alpha Cognition value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alpha Cognition competition to find correlations between indicators driving Alpha Cognition's intrinsic value. More Info.Alpha Cognition is rated second in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alpha Cognition's earnings, one of the primary drivers of an investment's value.About Alpha Cognition Financial Statements
Alpha Cognition stakeholders use historical fundamental indicators, such as Alpha Cognition's revenue or net income, to determine how well the company is positioned to perform in the future. Although Alpha Cognition investors may analyze each financial statement separately, they are all interrelated. For example, changes in Alpha Cognition's assets and liabilities are reflected in the revenues and expenses on Alpha Cognition's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Alpha Cognition. Please read more on our technical analysis and fundamental analysis pages.
Alpha Cognition Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for Alzheimers disease and amyotrophic lateral sclerosis . Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada. Alpha Cognition is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Alpha OTC Stock
Alpha Cognition financial ratios help investors to determine whether Alpha OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alpha with respect to the benefits of owning Alpha Cognition security.